Exosome-transmitted circular RNA hsa_circ_0051443 suppresses hepatocellular carcinoma progression

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Extracellular communication within the tumor microenvironment is crucial for cancer progression.
• Hepatocellular carcinoma (HCC) is a significant global health concern, necessitating novel diagnostic and therapeutic strategies.

Purpose of the Study:

• To investigate the role of circ-0051443 in hepatocellular carcinoma (HCC).
• To determine if exosomal circ-0051443 can serve as a diagnostic biomarker and therapeutic target for HCC.

Main Methods:

• Quantitative reverse transcription-polymerase chain reaction (qRT-PCR) to assess circ-0051443 levels.
• Exosome isolation and characterization.
• In vitro cell-based assays and in vivo xenograft mouse models.
• Receiver operating characteristic (ROC) curve analysis.

Main Results:

• Circ-0051443 levels were significantly lower in plasma exosomes and tissues of HCC patients compared to healthy controls.
• Exosomal circ-0051443 effectively distinguished HCC patients from controls.
• Circ-0051443, delivered via exosomes, suppressed HCC cell proliferation, induced apoptosis, and arrested the cell cycle.
• Exosomal circ-0051443 reduced xenograft tumor weight and volume in mice by upregulating BAK1 expression, which is mediated through competitive binding to miR-331-3p.

Conclusions:

• Exosomal circ-0051443 is a potential non-invasive biomarker for HCC diagnosis.
• Exosomal circ-0051443 demonstrates therapeutic potential for HCC by inhibiting tumor progression.
• The circ-0051443/miR-331-3p/BAK1 axis represents a novel mechanism in HCC pathogenesis and a potential therapeutic target.